WO2012021016A3 - Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient - Google Patents
Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient Download PDFInfo
- Publication number
- WO2012021016A3 WO2012021016A3 PCT/KR2011/005916 KR2011005916W WO2012021016A3 WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3 KR 2011005916 W KR2011005916 W KR 2011005916W WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer activity
- active ingredient
- composition including
- including same
- lactobacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention was conceived from the discovery of anti-cancer activity in lactobacillus out of many types of bacteria isolated while observing food-derived fermentation strains having the ability to ferment lactobacillus in apples, and provides lactobacillus casei (accession no. KCCM11072) having anti-cancer activity and the anti-cancer activity composition including same as an active ingredient, which can be used as a medical supply or as a health supplement food.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020100077908A KR20120015644A (en) | 2010-08-12 | 2010-08-12 | Lactobacillus strain having anticancer activity and anticancer active composition comprising the same as an active ingredient |
| KR10-2010-0077908 | 2010-08-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| WO2012021016A2 WO2012021016A2 (en) | 2012-02-16 |
| WO2012021016A3 true WO2012021016A3 (en) | 2012-05-10 |
| WO2012021016A9 WO2012021016A9 (en) | 2012-06-28 |
Family
ID=45568066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2011/005916 Ceased WO2012021016A2 (en) | 2010-08-12 | 2011-08-11 | Lacobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR20120015644A (en) |
| WO (1) | WO2012021016A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101910808B1 (en) * | 2016-11-28 | 2018-10-24 | 주식회사 쎌바이오텍 | Protein P8 Derived from Lactic Acid Bacteria and Its Use as Anti-Caner Agent |
| KR102680587B1 (en) * | 2018-05-28 | 2024-07-03 | 주식회사 쎌바이오텍 | Active Fragment Peptide of Protein Derived from Lactic Acid Bacteria and Use of the Same |
| KR102457422B1 (en) * | 2022-05-04 | 2022-10-21 | 주식회사 메디오젠 | Composition for preventing or treating colorectal cancer comprising a mixed strain of probiotics |
| CN116948916B (en) * | 2023-08-11 | 2024-06-11 | 四川大学 | Lactobacillus casei and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000038058A (en) * | 1998-12-03 | 2000-07-05 | 이은선 | New lactobacillus casei ky 22713 which ferments mistletoe |
| WO2003045405A2 (en) * | 2001-11-27 | 2003-06-05 | Bio-K Plus International Inc. | Lactic acid bacteria and their use for treating and preventing cancer |
| KR100411198B1 (en) * | 2001-03-13 | 2003-12-18 | 매일유업주식회사 | Formulation for inhibiting proliferation of tumor cell line |
| KR20100008831A (en) * | 2008-07-17 | 2010-01-27 | 주식회사 쎌바이오텍 | Anti-cancer composition comprising a culture fluid of lactobacillus casei as an effective component |
-
2010
- 2010-08-12 KR KR1020100077908A patent/KR20120015644A/en not_active Ceased
-
2011
- 2011-08-11 WO PCT/KR2011/005916 patent/WO2012021016A2/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000038058A (en) * | 1998-12-03 | 2000-07-05 | 이은선 | New lactobacillus casei ky 22713 which ferments mistletoe |
| KR100411198B1 (en) * | 2001-03-13 | 2003-12-18 | 매일유업주식회사 | Formulation for inhibiting proliferation of tumor cell line |
| WO2003045405A2 (en) * | 2001-11-27 | 2003-06-05 | Bio-K Plus International Inc. | Lactic acid bacteria and their use for treating and preventing cancer |
| KR20100008831A (en) * | 2008-07-17 | 2010-01-27 | 주식회사 쎌바이오텍 | Anti-cancer composition comprising a culture fluid of lactobacillus casei as an effective component |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012021016A9 (en) | 2012-06-28 |
| WO2012021016A2 (en) | 2012-02-16 |
| KR20120015644A (en) | 2012-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY172363A (en) | Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof | |
| RU2013153578A (en) | POLYBACTERIAL DRUG WITH ADVANTAGES FOR HEALTH: WITH ANTIOXIDANT EFFECT, REDUCED CONCENTRATION OF CHOLESTEROL, ANTI-INFLAMMATIVE EFFECT AND SUSTAINABILITY | |
| EP4257194A3 (en) | Use of microbial communities for human and animal health | |
| UA46234U (en) | Composition of ingredients of bread kvass | |
| WO2009013709A3 (en) | Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same | |
| WO2009142472A3 (en) | Bifidobacteria that produces folic acid, food composition and use of said bifidobacteria | |
| MX355955B (en) | Synergistic antimicrobial effect. | |
| RU2010147343A (en) | ISOLATED microorganism strain Lactobacillus plantarum Inducia DSM 21379 as probiotics, strengthens Innate immunity of the body, products, and compositions containing UPOMOMYANUTY microorganisms, and the use of said microorganisms for the preparation of a medicament that enhances the Cellular immunity | |
| ATE551419T1 (en) | BACTERIAL STRAIN WITH ANTIALLERGIC ACTIVITY AND DRINK, FOOD AND ANTIALLERGIC DRUG WITH CELL OF THE BACTERIA STRAIN | |
| UA118250C2 (en) | APPLICATION OF LACTIC ACID BACTERIA TO OBTAIN ENZYMED FOODSTUFFS WITH INCREASED NATURAL SWEET | |
| IN2012DN01638A (en) | ||
| MX2013004343A (en) | Texturizing lactic acid bacteria strains. | |
| WO2011162523A3 (en) | Composition for preventing or treating osteoporosis, containing ssangwhatang or lactobacillus fermented product thereof | |
| WO2009066681A1 (en) | Lactic acid bacterium-containing preparation | |
| MX339951B (en) | Bacillus subtilis isolate from corn. | |
| MX337716B (en) | Lactic acid bacterium-containing preparation. | |
| EP1812023B8 (en) | Lactic acid bacteria as probiotic strains and compositions containing same | |
| MX2012007970A (en) | Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field. | |
| IN2012DN02283A (en) | ||
| WO2012021016A3 (en) | Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient | |
| TW200700074A (en) | Inducer of t cell apoptosis | |
| WO2011031145A3 (en) | Improved soy milk fermentation | |
| WO2011073769A3 (en) | Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition | |
| CA2567976A1 (en) | A composition having immunoregulating activities comprising lactobacillus pentosus | |
| WO2006119780A3 (en) | New antibiotic-sensitive lactic acid bacteria strains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11816632 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 11816632 Country of ref document: EP Kind code of ref document: A2 |